Loading...

Scientific Industries

OTCPK:SCND
Snowflake Description

Flawless balance sheet and undervalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
SCND
OTCPK
$6M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Scientific Industries, Inc. provides benchtop laboratory equipment, customized catalyst research instruments, and bioprocessing systems and products worldwide. The last earnings update was 65 days ago. More info.


Add to Portfolio Compare Print
SCND Share Price and Events
7 Day Returns
4.6%
OTCPK:SCND
-2.7%
US Medical Equipment
0.8%
US Market
1 Year Returns
40%
OTCPK:SCND
16.2%
US Medical Equipment
5.9%
US Market
SCND Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Scientific Industries (SCND) 4.6% -12.3% 17.3% 40% 40% 12.7%
US Medical Equipment -2.7% -3.3% 7.8% 16.2% 56.5% 96%
US Market 0.8% 2.6% 10.6% 5.9% 37.7% 45.5%
1 Year Return vs Industry and Market
  • SCND outperformed the Medical Equipment industry which returned 16.2% over the past year.
  • SCND outperformed the Market in United States of America which returned 5.9% over the past year.
Price Volatility
SCND
Industry
5yr Volatility vs Market

SCND Value

 Is Scientific Industries undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Scientific Industries to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Scientific Industries.

OTCPK:SCND Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Extrapolated from most recent financials. See below
Discount Rate (Cost of Equity) See below 8.4%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for OTCPK:SCND
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Medical Equipment Unlevered Beta Simply Wall St/ S&P Global 0.93
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.932 (1 + (1- 21%) (0.04%))
0.955
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.95
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (0.955 * 5.96%)
8.42%

Discounted Cash Flow Calculation for OTCPK:SCND using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Scientific Industries is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

OTCPK:SCND DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 8.42%)
2019 0.82 Est @ 14.22% 0.75
2020 0.91 Est @ 10.77% 0.77
2021 0.98 Est @ 8.36% 0.77
2022 1.05 Est @ 6.67% 0.76
2023 1.10 Est @ 5.49% 0.74
2024 1.16 Est @ 4.66% 0.71
2025 1.20 Est @ 4.08% 0.68
2026 1.25 Est @ 3.68% 0.65
2027 1.29 Est @ 3.39% 0.62
2028 1.33 Est @ 3.19% 0.59
Present value of next 10 years cash flows $7.05
OTCPK:SCND DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $1.33 × (1 + 2.73%) ÷ (8.42% – 2.73%)
$24.02
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $24.02 ÷ (1 + 8.42%)10
$10.70
OTCPK:SCND Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $7.05 + $10.70
$17.75
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $17.75 / 1.49
$11.88
OTCPK:SCND Discount to Share Price
Calculation Result
Value per share (USD) From above. $11.88
Current discount Discount to share price of $4.34
= -1 x ($4.34 - $11.88) / $11.88
63.5%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Scientific Industries is available for.
Intrinsic value
>50%
Share price is $4.34 vs Future cash flow value of $11.88
Current Discount Checks
For Scientific Industries to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Scientific Industries's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Scientific Industries's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Scientific Industries's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Scientific Industries's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:SCND PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $0.28
OTCPK:SCND Share Price ** OTCPK (2019-04-18) in USD $4.34
United States of America Medical Equipment Industry PE Ratio Median Figure of 63 Publicly-Listed Medical Equipment Companies 39.41x
United States of America Market PE Ratio Median Figure of 3,078 Publicly-Listed Companies 18.23x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Scientific Industries.

OTCPK:SCND PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OTCPK:SCND Share Price ÷ EPS (both in USD)

= 4.34 ÷ 0.28

15.68x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Scientific Industries is good value based on earnings compared to the US Medical Equipment industry average.
  • Scientific Industries is good value based on earnings compared to the United States of America market.
Price based on expected Growth
Does Scientific Industries's expected growth come at a high price?
Raw Data
OTCPK:SCND PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 15.68x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
15.1%per year
United States of America Medical Equipment Industry PEG Ratio Median Figure of 54 Publicly-Listed Medical Equipment Companies 2.56x
United States of America Market PEG Ratio Median Figure of 2,108 Publicly-Listed Companies 1.56x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Scientific Industries, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Scientific Industries's assets?
Raw Data
OTCPK:SCND PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $3.95
OTCPK:SCND Share Price * OTCPK (2019-04-18) in USD $4.34
United States of America Medical Equipment Industry PB Ratio Median Figure of 185 Publicly-Listed Medical Equipment Companies 4.34x
United States of America Market PB Ratio Median Figure of 5,172 Publicly-Listed Companies 1.93x
OTCPK:SCND PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OTCPK:SCND Share Price ÷ Book Value per Share (both in USD)

= 4.34 ÷ 3.95

1.1x

* Primary Listing of Scientific Industries.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Scientific Industries is good value based on assets compared to the US Medical Equipment industry average.
X
Value checks
We assess Scientific Industries's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Scientific Industries has a total score of 5/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

SCND Future Performance

 How is Scientific Industries expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Scientific Industries, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
15.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Scientific Industries expected to grow at an attractive rate?
  • Scientific Industries's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Scientific Industries's earnings growth is expected to exceed the United States of America market average.
  • Unable to compare Scientific Industries's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:SCND Future Growth Rates Data Sources
Data Point Source Value (per year)
OTCPK:SCND Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 15.1%
United States of America Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 20.4%
United States of America Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 7.2%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:SCND Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:SCND Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 10 1 0
2018-09-30 9 1 0
2018-06-30 8 0 0
2018-03-31 7 0 0
2017-12-31 7 0 0
2017-09-30 8 0 0
2017-06-30 8 0 0
2017-03-31 11 1 0
2016-12-31 10 1 0
2016-09-30 10 1 0
2016-06-30 10 1 0
2016-03-31 8 0 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Scientific Industries's earnings are expected to grow by 15.1% yearly, however this is not considered high growth (20% yearly).
  • Unable to determine if Scientific Industries is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:SCND Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Scientific Industries Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:SCND Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 0.28
2018-09-30 0.14
2018-06-30 -0.11
2018-03-31 -0.33
2017-12-31 -0.26
2017-09-30 -0.17
2017-06-30 -0.05
2017-03-31 0.15
2016-12-31 0.09
2016-09-30 0.12
2016-06-30 0.11
2016-03-31 0.19

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Scientific Industries will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Scientific Industries's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Scientific Industries has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

SCND Past Performance

  How has Scientific Industries performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Scientific Industries's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Scientific Industries's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
  • Scientific Industries has become profitable in the last year making the earnings growth rate difficult to compare to the 5-year average.
  • Scientific Industries has become profitable in the last year making it difficult to compare the US Medical Equipment industry average.
Earnings and Revenue History
Scientific Industries's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Scientific Industries Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:SCND Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 9.51 0.41 2.82 0.49
2018-09-30 9.24 0.21 2.73 0.51
2018-06-30 8.48 -0.16 2.71 0.52
2018-03-31 7.27 -0.49 2.62 0.48
2017-12-31 7.08 -0.38 2.54 0.48
2017-09-30 7.87 -0.26 2.55 0.45
2017-06-30 8.15 -0.07 2.55 0.44
2017-03-31 10.60 0.23 3.21 0.42
2016-12-31 10.37 0.13 3.18 0.40
2016-09-30 9.71 0.18 3.16 0.38
2016-06-30 9.60 0.17 3.11 0.35
2016-03-31 7.91 0.29 2.55 0.34
2015-12-31 7.97 0.34 2.57 0.34
2015-09-30 7.63 0.11 2.70 0.37
2015-06-30 7.85 0.01 2.75 0.39
2015-03-31 6.91 -0.43 2.61 0.44
2014-12-31 6.96 -0.51 2.63 0.46
2014-09-30 7.02 -0.24 2.43 0.44
2014-06-30 6.79 -0.08 2.31 0.43
2014-03-31 7.25 0.25 2.27 0.40
2013-12-31 7.09 0.46 2.12 0.38
2013-09-30 7.22 0.46 2.06 0.43
2013-06-30 7.13 0.40 2.00 0.45
2013-03-31 6.80 0.30 1.93 0.48
2012-12-31 6.69 0.14 1.91 0.51
2012-09-30 6.01 -0.06 1.90 0.45
2012-06-30 6.20 0.07 1.94 0.38

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Scientific Industries has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Scientific Industries used its assets less efficiently than the US Medical Equipment industry average last year based on Return on Assets.
  • Scientific Industries has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Scientific Industries's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Scientific Industries has a total score of 1/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

SCND Health

 How is Scientific Industries's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Scientific Industries's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Scientific Industries is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Scientific Industries's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Scientific Industries's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 2406x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Scientific Industries Company Filings, last reported 3 months ago.

OTCPK:SCND Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 5.91 0.00 1.67
2018-09-30 5.78 0.00 1.83
2018-06-30 5.70 0.01 1.37
2018-03-31 5.50 0.05 0.99
2017-12-31 5.54 0.05 1.02
2017-09-30 5.60 0.01 1.25
2017-06-30 5.83 0.01 1.32
2017-03-31 5.96 0.01 1.51
2016-12-31 5.88 0.27 1.19
2016-09-30 5.89 0.02 1.26
2016-06-30 5.93 0.02 1.54
2016-03-31 5.76 1.17 1.36
2015-12-31 5.78 0.67 0.95
2015-09-30 5.69 0.40 0.81
2015-06-30 5.75 0.20 0.76
2015-03-31 5.43 0.10 0.64
2014-12-31 5.40 0.25 0.58
2014-09-30 5.54 0.21 0.73
2014-06-30 5.68 0.03 0.91
2014-03-31 5.82 0.13 0.82
2013-12-31 5.44 0.12 1.75
2013-09-30 5.29 0.09 1.64
2013-06-30 5.40 0.11 1.84
2013-03-31 5.24 0.12 1.68
2012-12-31 5.09 0.14 1.39
2012-09-30 4.94 0.16 1.48
2012-06-30 5.03 0.18 1.49
  • Scientific Industries's level of debt (0%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (2.1% vs 0% today).
  • Debt is well covered by operating cash flow (31516%, greater than 20% of total debt).
  • Scientific Industries earns more interest than it pays, coverage of interest payments is not a concern.
X
Financial health checks
We assess Scientific Industries's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Scientific Industries has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

SCND Dividends

 What is Scientific Industries's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.15%
Current annual income from Scientific Industries dividends.
If you bought $2,000 of Scientific Industries shares you are expected to receive $23 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Scientific Industries's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.4%).
  • Scientific Industries's dividend is below the markets top 25% of dividend payers in United States of America (3.63%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:SCND Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 24 Stocks 1.3%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2009 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

OTCPK:SCND Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-02-13 0.050 1.137
2018-09-28 0.000 0.000
2017-09-29 0.030 0.949
2017-05-16 0.030 0.946
2016-11-15 0.030 1.024
2015-11-12 0.000 0.000
2015-09-28 0.000 0.000
2015-05-14 0.000 0.000
2015-02-13 0.000 0.000
2014-11-13 0.000 0.000
2013-09-27 0.080 2.273
2012-11-14 0.030 1.150
2012-09-24 0.030 1.653
2011-09-16 0.050 2.270
2010-10-04 0.090 2.744
2009-09-23 0.060 1.943
2009-04-20 0.080 4.161

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Dividends per share have fallen over the past 10 years.
Current Payout to shareholders
What portion of Scientific Industries's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (5.5x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Scientific Industries's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Scientific Industries afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Scientific Industries has a total score of 1/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

SCND Management

 What is the CEO of Scientific Industries's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Helena Santos
COMPENSATION $219,800
AGE 54
TENURE AS CEO 16.7 years
CEO Bio

Ms. Helena R. Santos, CPA., has been the President, Chief Executive Officer and Treasurer of Scientific Industries Inc. since August 29, 2002. Ms. Santos serves as the Chief Financial Officer and Compliance Officer of Scientific Industries Inc. She served as Principal Financial Officer of Scientific Industries Inc. Ms. Santos has been employed by Scientific Industries Inc. since 1994 and served as Vice President and Controller since 1997 and Secretary since May 2001. She has been Director at Scientific Industries Inc., since 2009. Prior to joining Scientific Industries Inc., she was an internal auditor with a major defense contractor from March 1991 to April 1994. Prior to March 1991, she was employed in public accounting.

CEO Compensation
  • Helena's compensation has increased in line with Scientific Industries recently becoming profitable.
  • Helena's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Scientific Industries management team in years:

1.9
Average Tenure
55.5
Average Age
  • The average tenure for the Scientific Industries management team is less than 2 years, this suggests a new team.
Management Team

Joseph Cremonese

TITLE
Chairman
COMPENSATION
$78K
AGE
82

Helena Santos

TITLE
CEO, President
COMPENSATION
$220K
AGE
54
TENURE
16.7 yrs

Brookman March

TITLE
VP of Corporate Development & Strategy and VP of Sales of Altamira
COMPENSATION
$175K
AGE
73
TENURE
1.8 yrs

Karl Nowosielski

TITLE
President of Torbal Products Div. - Benchtop Laboratory Equipment Ops & Director of Marketing
COMPENSATION
$186K
AGE
39

Robert Nichols

TITLE
President of Genie Products Division - the Benchtop Laboratory Equipment Operations & Secretary
COMPENSATION
$173K
AGE
57

Anthony Mitri

TITLE
President of Altamira
COMPENSATION
$116K
AGE
36
TENURE
1.9 yrs
Board of Directors Tenure

Average tenure and age of the Scientific Industries board of directors in years:

10.3
Average Tenure
62
Average Age
  • The average tenure for the Scientific Industries board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Joseph Cremonese

TITLE
Chairman
COMPENSATION
$78K
AGE
82
TENURE
13.2 yrs

Helena Santos

TITLE
CEO, President
COMPENSATION
$220K
AGE
54
TENURE
10.3 yrs

James Segasture

TITLE
Director
COMPENSATION
$15K
AGE
82
TENURE
28.3 yrs

Grace Morin

TITLE
Director
COMPENSATION
$22K
AGE
70
TENURE
12.3 yrs

John F. Watkins

TITLE
Director
COMPENSATION
$15K
AGE
51
TENURE
2.3 yrs

John Moore

TITLE
Director
AGE
53
TENURE
0.3 yrs

Marcus Frampton

TITLE
Director
TENURE
0.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Scientific Industries's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Scientific Industries has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

SCND News

Simply Wall St News

SCND Company Info

Description

Scientific Industries, Inc. provides benchtop laboratory equipment, customized catalyst research instruments, and bioprocessing systems and products worldwide. It offers vortex mixers to mix the contents of test tubes, beakers, and other containers by placing such containers on a rotating cup or other attachments; and various mixers and shakers, such as high speed touch mixers, mixers with an integral timer, cell disruptors, microplate mixers, vortex mixers incorporating digital control and display, and multi-vessel vortex mixers and orbital shakers. The company also provides benchtop multi-purpose rotators and rockers to rotate and rock various containers; refrigerated incubators and incubator shakers for shaking and stirring functions; and magnetic stirrers, including high/low programmable magnetic stirrers, four-place high/low programmable magnetic stirrers, and large volume magnetic and four-place general purpose stirrers. In addition, it offers AMI-300 catalyst characterization instrument for temperature-programmed catalyst characterization experiments; and catalyst research instrument products, such as reactor systems, high throughput systems, and micro-activity reactors. Further, the company provides bioprocessing systems comprising coaster systems using disposable sensors for vessels with volumes ranging from 250 milliliter to 5 liters; and mechanical balances, moisture analyzers, and force gauges, as well as pharmacy, laboratory, and industrial digital scales. Its products are used for research purposes by universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, petrochemical companies, and other industries performing laboratory-scale research. The company markets its products under the Genie and Torbal brand names directly, as well as through laboratory equipment distributors and online. Scientific Industries, Inc. was founded in 1954 and is headquartered in Bohemia, New York.

Details
Name: Scientific Industries, Inc.
SCND
Exchange: OTCPK
Founded: 1954
$6,484,446
1,494,112
Website: http://www.scientificindustries.com
Address: Scientific Industries, Inc.
80 Orville Drive,
Suite 102,
Bohemia,
New York, 11716,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OTCPK SCND Common Stock Pink Sheets LLC US USD 13. Dec 1972
Number of employees
Current staff
Staff numbers
32
Scientific Industries employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/18 23:41
End of day share price update: 2019/04/18 00:00
Last earnings filing: 2019/02/12
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.